King Faisal Specialist Hospital & Research Centre (KFSHRC) has signed five key international agreements during the Saudi-US ...
The decision supports stronger international participation, enhanced business opportunities and an impactful launch edition for the region's process industries, directly supporting Vision 2030's ...
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...
Monash University's Kate Strayer-Benton and Andrew R. Snyder, PhD. join the program live from Bio 2026 in San Diego, where ...
NKGen Biotech, Inc. (OTC: NKGN) ('NKGen” or the 'Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...
Our editorial team delve into the key takeaways from the 2026 HLTH Europe conference and the 2026 BIO International ...
Train to Busan’s director just dropped the first look at his return to zombie horror, and it looks absolutely terrifying.
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative ...
"First they crawled... now they seem to be evolving through information exchange." 🧟 Evolving zombies! Well Go USA has ...
The fireside chat is scheduled for 1:00 p.m. ET on June 30, 2026, and will be moderated by Matthew Caufield, Senior Research Healthcare Analyst at H.C. Wainwright & Co. FibroBiologics will be ...
Shares in Clarity Pharmaceuticals Ltd (ASX: CU6) were trading more than 10% higher on good news about its prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results